Home > Investors
Investor Relations Home
E-mail Page Print Page RSS Feeds E-mail Alerts IR Contacts Financial Tear Sheet 
About Us
Download Documentation ALN-PCSsc Phase 1 Clinical Results Presentation
Download Documentation Update on ABP-700
Download Documentation ALN-PCSsc Phase 1 Clinical Results Presentation
Download Documentation ABP-700 & MDCO-216 Conference Call Presentation
Download Documentation Jefferies 2015 Global Healthcare Conference
Corporate Profile
The Medicines Company provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients.
Stock Quote
MDCO (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$29.13
Change (%) Stock is Down 0.02 (0.07%)
Volume505,537
Data as of 02/12/16 2:58 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent News
DateTitle 
02/05/16The Medicines Company Announces Clive Meanwell, MD, PhD, Chief Executive Officer, Is the Recipient of the 2016 Dr. Sol J. Barer Award for Vision, Innovation and Leadership
Company also receives BioNJ Innovator Award for new drug approvals in 2015 PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb. 5, 2016-- The Medicines Company (NASDAQ:MDCO) today announced that its founder and Chief Executive Officer, Clive Meanwell, MD, PhD, has been awarded the 2016 Dr. Sol J. Barer Award for Vision, Innovation, and Leadership. Named for Sol J. Barer, PhD, founder and former Chairman and Chief Executive Officer of Celgene Co... 
Printer Friendly Version
02/04/16The Medicines Company to Announce Fourth Quarter and Full Year 2015 Financial Results on Wednesday, February 17, 2016
PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb. 4, 2016-- The Medicines Company (NASDAQ:MDCO) has scheduled its quarterly conference call for Wednesday, February 17th at 8:30 a.m. Eastern Time to discuss fourth quarter and full year 2015 financial results, operational developments, and outlook for 2016. The conference call will be available via phone and webcast. The dial-in information is listed below: Domestic Dial In: + 1 (877) 359-9508... 
Printer Friendly Version
02/03/16The Medicines Company Appoints Alexander J. Denner, Ph.D. to its Board of Directors
PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb. 3, 2016-- The Medicines Company (NASDAQ:MDCO) today announced that it has appointed Alexander J. Denner, Ph.D. to its Board of Directors. Dr. Denner will serve as a Class III director with a term expiring at the Company’s 2018 Annual Meeting of Stockholders. He will also serve on the Company’s Nominating and Corporate Governance Committee. With the appointment of Dr. Denner, which was effective on February 2, 2016,... 
Printer Friendly Version
02/02/16The Medicines Company to Participate in Leerink Partners 5th Annual Global Healthcare Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb. 2, 2016-- The Medicines Company (NASDAQ:MDCO) is scheduled to participate at the Leerink Partners 5th Annual Global Healthcare Conference in New York, NY on Wednesday, February 10th at 10:40am EST. The session will be webcast with a link available at The Medicines Company’s website http://www.themedicinescompany.com. About The Medicines Company The Medicines Company's purpose is to sa... 
Printer Friendly Version
Upcoming Events
DateTitle
02/17/16 8:30 a.m. ET
Q4 2015 The Medicines Company Earnings Conference Call

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.